Bee Vectoring Technologies and BioSafe Systems Sign Memorandum of Understanding on Multi-Faceted Business Collaborations

Press Releases
Posted on January 12, 2022

Bee Vectoring Technologies and BioSafe Systems Sign Memorandum of Understanding on
Multi-Faceted Business Collaborations

Mississauga, ON Canada, Sacramento, CA USA and East Hartford, CT USA (January 12, 2022) – Bee Vectoring Technologies International Inc. (“BVT”) (CSE: BEE) (OTCQB: BEVVF) (CVE:BEE) and BioSafe Systems, LLC (“BioSafe”) today jointly announced they have signed a Memorandum of Understanding (MOU) where the companies have agreed to enter into detailed discussions on multiple business partnership projects that call upon each other’s expertise. BioSafe and BVT are both leaders in the agricultural biologicals industry with a similar customer base, and offer services and products that are complimentary to one another.

The projects will enable both companies to expand each other’s product offerings, markets and customer base. Opportunities include pairing BioSafe biologicals with BVT’s bee vectoring system, and using BVT’s Clonostachys rosea CR-7 (CR-7) strain for non-bee-vectoring applications. Specific agreements in these areas will follow after evaluations and more detailed discussions on business terms.

BioSafe has a 23 year history as an innovator of environmentally sustainable products and has a team of 100 people across the US, Mexico, Canada, and into South America. BioSafe serves a broad customer base in the Agriculture, Horticulture, Post Harvest/Food Safety, Aquatics, Home and Garden, Turf, and Commercial/Industrial Sanitation markets.

BVT has pioneered a natural precision agriculture system proven to replace chemical pesticides and wasteful plant protection product spray applications by delivering biological pesticide alternatives to crops using commercially managed bees while increasing crop yields. BVT has also been testing and is seeing positive results for the use of its proprietary CR-7 strain in foliar and soil applications.

“We are excited to announce this inaugural arrangement with an industry partner that is a leader in biological products,” said Ashish Malik, CEO of BVT. “Our strategy is to build partnerships with established partners to accelerate our growth and broaden our customer reach. Therefore, being able to attract the attention of an industry leader such as BioSafe validates that our technology is gaining momentum among growers and in the market. BioSafe’s multi-market and multi-channel focus will help BVT accelerate growth and maximize shareholder value.”

“We are excited about the potential to work closely with such an innovative company like BVT. Our target markets are the same, and we share similar missions and beliefs,” said Rob Larose, President and CEO of BioSafe Systems. “The mission of BioSafe Systems is to provide disease control solutions utilizing reduced-risk chemistries that do not negatively impact the health and safety of people and the environment. We only develop, manufacture, and promote products that meet our standards of environmentalism and sustainability, and BVT perfectly meets these key criteria.”

Bee Vectoring Technologies International Inc.

BVT, an agriculture technology company, is a market disruptor with a significant global market opportunity in the $240 billion crop protection and fertilizer market. BVT has pioneered a natural precision agriculture system that replaces chemical pesticides and wasteful plant protection product spray applications by delivering biological pesticide alternatives to crops using commercially grown bees. BVT’s award-winning technology, precision vectoring, is completely harmless to bees and allows minute amounts of naturally-derived pesticides (called biologicals) to be delivered directly to blooms, providing improved crop protection and yield results than traditional chemical pesticides – and improving the health of the soil, the microbiome and the environment. Currently, BVT has over 65 granted patents, over 35 patents pending in all major agricultural countries worldwide, and has US EPA registration of its Vectorite™ with CR-7 (EPA Registration No. 90641-2) for sale as a registered biological fungicide for use on the labeled crops.

Additional information can be viewed at the Company’s website To receive regular news updates from the Company, subscribe at

About BioSafe Systems, LLC

At BioSafe Systems, we pride ourselves on being innovators of environmentally sustainable practices and products to protect crops, water, and people across North America. Since 1998, we have engaged with customers, researchers, and regulatory agencies to remain at the forefront of innovation and service while continuing our mission to provide simple, sustainable, and effective solutions.

Additional information can be viewed at the Company’s website

BVT Company Contact:
Ashish Malik, President & CEO, BVT

BVT Investor Contact:
Babak Pedram, Investor Relations
Virtus Advisory Group
Tel: 416-995-8651

BioSafe Company Contact:
Rob Larose
Toll Free: 1-888-273-3088

The CSE has neither approved nor disapproved the contents of this press release. The CSE does not accept responsibility for the adequacy or accuracy of this release. Certain statements contained in this press release constitute “forward-looking information” as such term is defined in applicable Canadian securities legislation. The words “may”, “would”, “could”, “should”, “potential”, “will”, “seek”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” and similar expressions as they relate to the Company, “annual revenue potential”, are intended to identify forward-looking information. All statements other than statements of historical fact may be forward-looking information. Such statements reflect the Company’s current views and intentions with respect to future events, and current information available to the Company, and are subject to certain risks, uncertainties and assumptions, including: planted acres, selling price of competitive chemical pesticides and the US to Canadian dollar exchange rate. Material factors or assumptions were applied in providing forward-looking information. Many factors could cause the actual results, performance or achievements that may be expressed or implied by such forward-looking information to vary from those described herein should one or more of these risks or uncertainties materialize. These factors include changes in law, competition, litigation, the ability to implement business strategies and pursue business opportunities, state of the capital markets, the availability of funds and resources to pursue operations, new technologies, the ability to protect intellectual property rights, the ability to obtain patent protection for products, third-party intellectual property infringement claims, regulatory changes affecting products, failing research and development activities, the ability to reach and sustain profitability, dependence on business and technical experts, the ability to effectively manage business operations and growth, issuance of debt, dilution of existing securities, volatility of publicly traded securities, potential conflicts of interest, unlikelihood of dividend payments, the potential costs stemming from defending third-party intellectual property infringement claims, the ability to secure relationships with manufacturers and purchasers, as well as general economic, market and business conditions, as well as those risk factors discussed or referred to in the Company’s Filing Statement dated August 14,2020, filed with the CSE and securities regulatory authorities in certain provinces of Canada and available at Should any factor affect the Company in an unexpected manner, or should assumptions underlying the forward-looking information prove incorrect, the actual results or events may differ materially from the results or events predicted. Any such forward-looking information is expressly qualified in its entirety by this cautionary statement. Moreover, the Company does not assume responsibility for the accuracy or completeness of such forward-looking information. The forward-looking information included in this press release is made as of the date of this press release and the Company undertakes no obligation to publicly update or revise any forward-looking information, other than as required by applicable law. All figures are in Canadian dollars.